Functional effects of a monoclonal antibody directed against a distinct epitope on 4F2 molecular complex in human...

Area of Science:

• Immunology
• Cell Biology

Background:

• The 4F2 antigenic complex is expressed on various human cells, including monocytes and activated lymphocytes, but absent on resting lymphocytes.
• Monoclonal antibody (mAb) CB43 identifies a specific epitope on the 4F2 heterodimer, potentially on its light chain or conformation-dependent.

Purpose of the Study:

• To investigate the functional role of the epitope recognized by mAb CB43 on the 4F2 molecular complex.
• To determine the effects of mAb CB43 on peripheral blood mononuclear cells (PBMC) and their activation.

Main Methods:

• Binding of CB43 mAb to PBMC and assessment of comitogenic effects with anti-CD3 mAb.
• Measurement of cytokine release (IL-1 beta, IL-2, interferon-gamma) following CB43 mAb treatment.
• Depletion of CB43+ cells from PBMC and evaluation of proliferation, effector cell generation, and cytotoxic activity.

Main Results:

• CB43 mAb induced a dose-dependent comitogenic effect on PBMC in conjunction with anti-CD3 mAb, leading to IL-1 beta release.
• Pretreatment with CB43 mAb enhanced phytohemagglutinin-induced T lymphocyte proliferation but did not directly activate T lymphocytes.
• Depletion of CB43+ cells reduced proliferation and cytotoxic effector cell generation induced by Candida albicans mannoprotein (MP), impacting cytotoxic activity.

Conclusions:

• mAb CB43 identifies a distinct functional epitope on the 4F2 molecular complex.
• The 4F2 molecule, as identified by CB43, plays a role in cellular activation, particularly in responses to specific antigens like MP.
• CB43 mAb serves as a valuable tool for further research into the functions of the 4F2 complex in immune cell activation.